ADVISORY 1
They connect you with licensed medical providers and certified pharmacies to ensure your treatment is safe, reliable, and delivered straight to your door
The ADT treatment included 22.5 mg leuprolide acetate, a gonadotropin-releasing hormone (GnRH) agonist, and a daily dose of 50 mg bicalutamide, an androgen receptor antagonist ( Instruments Sleep quality was measured using the Patient Reported Outcomes Measurement Information System (PROMIS TM ) v1.0 Sleep Related Impairment (PROMIS-SRI) Short Form 8b, an eight-question form that quantifies the extent to which sleep impairment impacts daily life ( T -score with a mean of 50 ( T -score indicates better sleep, and a higher T -score indicates increased impairment due to reduced sleep ( T -score ranges from 29.4 to 83.2, with a mean of 50 ( T -score metric is anchored to the United States general population, and a cutoff T -score of 50 differentiates clinically meaningful fatigue in the oncology population ( Metabolomics Untargeted metabolomics analysis was performed at Metabolon, Inc., (Durham, NC, United States), as previously described ( via negative ionization following elution from a HILIC column (Waters UPLC BEH Amide 2.1 150 mm, 1.7 m) using a gradient consisting of water and acetonitrile with 10 mM ammonium formate, pH 10.8
[7] [8] Lactulose, another osmotic agent, may cause bloating and flatulence, which some patients find uncomfortable alongside GLP-1-related gastrointestinal effects
